Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
73.50
+0.71 (0.98%)
At close: Feb 12, 2026
55.19% (1Y)
| Market Cap | 4.87B +83.2% |
| Revenue (ttm) | 336.73M +22.0% |
| Net Income | 101.91M +49.3% |
| EPS | 1.54 +47.4% |
| Shares Out | 66.70M |
| PE Ratio | 47.41 |
| Forward PE | n/a |
| Dividend | 0.60 (0.82%) |
| Ex-Dividend Date | May 30, 2025 |
| Volume | 694,673 |
| Average Volume | 1,419,190 |
| Open | 73.00 |
| Previous Close | 72.79 |
| Day's Range | 72.40 - 74.56 |
| 52-Week Range | 41.40 - 92.50 |
| Beta | -0.05 |
| RSI | 53.10 |
| Earnings Date | Apr 28, 2026 |